510(k) K062025
K062025 is an FDA 510(k) premarket notification submitted by Corgenix, Inc. for the device "ASPIRINWORKS TEST KIT (11-DEHYDRO THROMBOXANE B2), MODEL 12136". The FDA issued a decision of Substantially Equivalent on May 29, 2007. The device falls under product code OBW (11-Dehydro Thromboxane B2 Kit, Urinary), a Class II device regulated under 21 CFR 864.5700. Corgenix, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 29, 2007
- Date Received
- July 18, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- 11-Dehydro Thromboxane B2 Kit, Urinary
- Device Class
- Class II
- Regulation Number
- 864.5700
- Review Panel
- HE
- Submission Type
The test kit is an enzyme-linked immunoassay (elisa) to determine levels of 11-dehydro thromboxane b2 (11dhtxb2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only.